1. Vascular Endothelial Growth Factor Receptor 2 Blockade Disrupts Postnatal Lung Development
   Sharon A. McGrath-Morrow et al, 2005, American Journal of Respiratory Cell and Molecular Biology CrossRef
2. Human Tumor Xenografts Recurring after Radiotherapy Are More Sensitive to Anti–Vascular Endothelial Growth Factor Receptor-2 Treatment than Treatment-Naive Tumors
   Sergey V. Kozin et al, 2007, Cancer Research CrossRef
3. A Vascular Endothelial Growth Factor Receptor-2 Inhibitor Enhances Antitumor Immunity through an Immune-Based Mechanism
   Elizabeth A. Manning et al, 2007, Clinical Cancer Research CrossRef
4. Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
   Daniel J. Hicklin et al, 2005, Journal of Clinical Oncology CrossRef
5. Vascular Endothelial Growth Factor Messenger RNA Expression Level Is Preserved in Liver Metastases Compared with Corresponding Primary Colorectal Cancer
   Hidekazu Kuramochi et al, 2006, Clinical Cancer Research CrossRef
6. Efficacy of Intrapleural or Intrapericardial Injection of Single Bevacizumab in the Treatment of Lung Cancer-Mediated Malignant Effusion
   Dongyun He et al, 2022, Canadian Respiratory Journal CrossRef
7. Phase II Study of the Flk-1 Tyrosine Kinase Inhibitor SU5416 in Advanced Melanoma
   Amy C. Peterson et al, 2004, Clinical Cancer Research CrossRef
8. Extracellular matrix gene expression profiling using microfluidics for colorectal carcinoma stratification
   Christopher J. Hayes et al, 2016, Biomicrofluidics CrossRef
9. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2
   Ji-yan Liu et al, 2003, Blood CrossRef
10. The Role of VEGF and EGFR Inhibition: Implications for Combining Anti–VEGF and Anti–EGFR Agents
    Josep Tabernero, 2007, Molecular Cancer Research CrossRef